MENU
+Compare
VVOS
Stock ticker: NASDAQ
AS OF
Nov 21 closing price
Price
$2.20
Change
+$0.08 (+3.77%)
Capitalization
16.51M

VVOS Vivos Therapeutics Forecast, Technical & Fundamental Analysis

Vivos Therapeutics Inc is a medical technology company... Show more

VVOS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for VVOS with price predictions
Nov 21, 2025

Momentum Indicator for VVOS turns negative, indicating new downward trend

VVOS saw its Momentum Indicator move below the 0 level on November 19, 2025. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 82 similar instances where the indicator turned negative. In of the 82 cases, the stock moved further down in the following days. The odds of a decline are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 50-day moving average for VVOS moved below the 200-day moving average on October 24, 2025. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where VVOS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for VVOS entered a downward trend on November 21, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where VVOS's RSI Indicator exited the oversold zone, of 44 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 4 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

The Moving Average Convergence Divergence (MACD) for VVOS just turned positive on November 10, 2025. Looking at past instances where VVOS's MACD turned positive, the stock continued to rise in of 36 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where VVOS advanced for three days, in of 222 cases, the price rose further within the following month. The odds of a continued upward trend are .

VVOS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.602) is normal, around the industry mean (63.026). P/E Ratio (0.000) is within average values for comparable stocks, (36.228). VVOS's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.720). VVOS has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.019). P/S Ratio (1.232) is also within normal values, averaging (84.164).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. VVOS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. VVOS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.

View a ticker or compare two or three
VVOS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

VVOS is expected to report earnings to fall 14.29% to -41 cents per share on March 26

Vivos Therapeutics VVOS Stock Earnings Reports
Q4'25
Est.
$-0.42
Q3'25
Missed
by $0.01
Q2'25
Missed
by $0.16
Q1'25
Missed
by $0.04
Q4'24
Beat
by $0.77
The last earnings report on November 19 showed earnings per share of -49 cents, missing the estimate of -47 cents. With 81.52K shares outstanding, the current market capitalization sits at 16.51M.
A.I. Advisor
published General Information

General Information

Industry MedicalNursingServices

Profile
Fundamentals
Details
Industry
N/A
Address
7921 Southpark Plaza
Phone
+1 844 672-4357
Employees
114
Web
https://www.vivos.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PRU106.752.63
+2.53%
Prudential Financial
CCOI17.050.39
+2.34%
Cogent Communications Holdings
EPR51.860.61
+1.19%
EPR Properties
TAVI10.41N/A
N/A
Tavia Acquisition Corp.
CCM3.60-0.37
-9.29%
Concord Medical Services Holding Limited

VVOS and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, VVOS has been loosely correlated with BCCOY. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if VVOS jumps, then BCCOY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VVOS
1D Price
Change %
VVOS100%
+3.77%
BCCOY - VVOS
43%
Loosely correlated
N/A
TPGVF - VVOS
32%
Poorly correlated
N/A
BIO - VVOS
29%
Poorly correlated
+4.31%
COCH - VVOS
26%
Poorly correlated
+3.44%
SHC - VVOS
26%
Poorly correlated
+3.42%
More

Groups containing VVOS

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VVOS
1D Price
Change %
VVOS100%
+3.77%
Medical/Nursing Services
industry (216 stocks)
22%
Poorly correlated
+2.88%
Health Services
industry (423 stocks)
11%
Poorly correlated
+2.34%